ARCUTIS BIOTHERAPEUTICS INC's ticker is ARQT and the CUSIP is 03969K108. A total of 145 filers reported holding ARCUTIS BIOTHERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $46,113,272 | -44.3% | 8,684,232 | 0.0% | 3.06% | -38.0% |
| Q2 2023 | $82,760,731 | -13.4% | 8,684,232 | 0.0% | 4.94% | -28.5% |
| Q1 2023 | $95,526,552 | -25.7% | 8,684,232 | 0.0% | 6.92% | -13.5% |
| Q4 2022 | $128,526,634 | -22.6% | 8,684,232 | 0.0% | 7.99% | -37.5% |
| Q3 2022 | $165,956,000 | -7.7% | 8,684,232 | +3.0% | 12.78% | -24.7% |
| Q2 2022 | $179,733,000 | +10.6% | 8,434,232 | 0.0% | 16.96% | +22.5% |
| Q1 2022 | $162,443,000 | – | 8,434,232 | – | 13.84% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 8,684,232 | $46,113,272 | 3.06% |
| Pivotal bioVenture Partners Investment Advisor LLC | 1,105,309 | $5,869,191 | 2.34% |
| Bain Capital Life Sciences Investors, LLC | 3,000,000 | $15,930,000 | 1.78% |
| Sio Capital Management, LLC | 635,969 | $3,376,995 | 1.04% |
| Rubric Capital Management LP | 5,034,530 | $26,733,354 | 1.00% |
| Tejara Capital Ltd | 309,179 | $1,641,740 | 0.93% |
| AlphaCentric Advisors LLC | 165,000 | $876,150 | 0.50% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,135,227 | $6,028,055 | 0.33% |
| Orbimed Advisors | 1,914,479 | $10,165,883 | 0.22% |
| Two Seas Capital LP | 164,807 | $875,125 | 0.18% |